Literature DB >> 12815694

Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis.

Matilde Inglese1, Belinda S Y Li, Henry Rusinek, James S Babb, Robert I Grossman, Oded Gonen.   

Abstract

It is well known that multiple sclerosis (MS) pathogenesis continues even during periods of clinical silence. To quantify the metabolic characteristics of this activity we compared the absolute levels of N-acetylaspartate (NAA), creatine (Cr), and choline (Cho) in the normal-appearing white matter (NAWM) between relapsing-remitting (RR) MS patients and controls. Metabolite concentrations were obtained with 3D proton MR spectroscopy at 1.5 T in a 480 cm(3) volume-of-interest (VOI), centered on the corpus callosum of 11 MS patients and 9 matched controls. Gray/white-matter/cerebral-spinal-fluid (CSF) volumes were obtained from MRI segmentation. Patients' average VOI tissue volume (V(T)), 410.8 +/- 24.0 cm(3), and metabolite levels, NAA = 6.33 +/- 0.70, Cr = 4.67 +/- 0.52, Cho = 1.40 +/- 0.17 mM, were different from the controls by -8%, -9%, +22% and +32%. The Cho level was the only single metric differentiating patients from controls at 100% specificity and >90% sensitivity. Diffusely elevated Cho and Cr probably reflect widespread microscopic inflammation, gliosis, or de- and remyelination in the NAWM. Both metabolites are potential prognostic indicators of current disease activity, preceding NAA decline and atrophy. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12815694     DOI: 10.1002/mrm.10481

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  56 in total

Review 1.  The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.

Authors:  Kedar R Mahajan; Daniel Ontaneda
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

2.  MR imaging and proton spectroscopy of neuronal injury in late-onset GM2 gangliosidosis.

Authors:  Matilde Inglese; Annette O Nusbaum; Gregory M Pastores; John Gianutsos; Edwin H Kolodny; Oded Gonen
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

Review 3.  Magnetic resonance spectroscopy in the monitoring of multiple sclerosis.

Authors:  Ponnada A Narayana
Journal:  J Neuroimaging       Date:  2005       Impact factor: 2.486

4.  Regional distributions of brain glutamate and glutamine in normal subjects.

Authors:  Mohammed Z Goryawala; Sulaiman Sheriff; Andrew A Maudsley
Journal:  NMR Biomed       Date:  2016-06-28       Impact factor: 4.044

5.  Multimodal mass spectrometric imaging of small molecules reveals distinct spatio-molecular signatures in differentially metastatic breast tumor models.

Authors:  Erika R Amstalden van Hove; Tiffany R Blackwell; Ivo Klinkert; Gert B Eijkel; Ron M A Heeren; Kristine Glunde
Journal:  Cancer Res       Date:  2010-11-02       Impact factor: 12.701

6.  Hyper-connectivity of the thalamus during early stages following mild traumatic brain injury.

Authors:  Chandler Sours; Elijah O George; Jiachen Zhuo; Steven Roys; Rao P Gullapalli
Journal:  Brain Imaging Behav       Date:  2015-09       Impact factor: 3.978

Review 7.  Imaging Biomarkers of the Neuroimmune System among Substance Use Disorders: A Systematic Review.

Authors:  Eric A Woodcock; Ansel T Hillmer; Graeme F Mason; Kelly P Cosgrove
Journal:  Mol Neuropsychiatry       Date:  2019-05-09

8.  The kynurenine pathway in adolescent depression: preliminary findings from a proton MR spectroscopy study.

Authors:  Vilma Gabbay; Leonard Liebes; Yisrael Katz; Songtao Liu; Sandra Mendoza; James S Babb; Rachel G Klein; Oded Gonen
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-09-21       Impact factor: 5.067

9.  Dirty-appearing white matter in multiple sclerosis: preliminary observations of myelin phospholipid and axonal loss.

Authors:  G R W Moore; C Laule; A Mackay; E Leung; D K B Li; G Zhao; A L Traboulsee; D W Paty
Journal:  J Neurol       Date:  2008-09-24       Impact factor: 4.849

10.  CT and MR imaging after placement of the GliaSite radiation therapy system to treat brain tumor: initial experience.

Authors:  Maria G Matheus; Mauricio Castillo; Matthew Ewend; Jeffrey K Smith; Lester Knock; Sharon Cush; David E Morris
Journal:  AJNR Am J Neuroradiol       Date:  2004-08       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.